Ral GTP 酶激活蛋白调节胰腺导管腺癌的恶性程度。
Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.
机构信息
Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
出版信息
Cancer Sci. 2021 Aug;112(8):3064-3073. doi: 10.1111/cas.14970. Epub 2021 Jun 15.
The small GTPases RalA and RalB are members of the Ras family and activated downstream of Ras. Ral proteins are found in GTP-bound active and GDP-bound inactive forms. The activation process is executed by guanine nucleotide exchange factors, while inactivation is mediated by GTPase-activating proteins (GAPs). RalGAPs are complexes that consist of a catalytic α1 or α2 subunit together with a common β subunit. Several reports implicate the importance of Ral in pancreatic ductal adenocarcinoma (PDAC). However, there are few reports on the relationship between levels of RalGAP expression and malignancy in PDAC. We generated RalGAPβ-deficient PDAC cells by CRISPR-Cas9 genome editing to investigate how increased Ral activity affects malignant phenotypes of PDAC cells. RalGAPβ-deficient PDAC cells exhibited several-fold higher Ral activity relative to control cells. They had a high migratory and invasive capacity. The RalGAPβ-deficient cells grew more rapidly than control cells when injected subcutaneously into nude mice. When injected into the spleen, the RalGAPβ-deficient cells formed larger splenic tumors with more liver metastases, and unlike controls, they disseminated into the abdominal cavity. These results indicate that RalGAPβ deficiency in PDAC cells contributes to high activities of RalA and RalB, leading to enhanced cell migration and invasion in vitro, and tumor growth and metastasis in vivo.
小 GTP 酶 RalA 和 RalB 是 Ras 家族的成员,下游激活 Ras。Ral 蛋白以 GTP 结合的活性形式和 GDP 结合的非活性形式存在。激活过程由鸟嘌呤核苷酸交换因子执行,而失活则由 GTP 酶激活蛋白 (GAP) 介导。RalGAPs 是由催化的α1 或α2 亚基与共同的β亚基组成的复合物。有几个报道表明 Ral 在胰腺导管腺癌 (PDAC) 中的重要性。然而,关于 RalGAP 表达水平与 PDAC 恶性程度之间的关系的报道很少。我们通过 CRISPR-Cas9 基因组编辑生成了 RalGAPβ 缺陷型 PDAC 细胞,以研究 Ral 活性增加如何影响 PDAC 细胞的恶性表型。与对照细胞相比,RalGAPβ 缺陷型 PDAC 细胞的 Ral 活性高出数倍。它们具有较高的迁移和侵袭能力。当将 RalGAPβ 缺陷型细胞皮下注射到裸鼠中时,它们的生长速度比对照细胞快。当注射到脾脏时,RalGAPβ 缺陷型细胞形成了更大的脾脏肿瘤,并伴有更多的肝转移,与对照细胞不同的是,它们扩散到了腹腔。这些结果表明,PDAC 细胞中 RalGAPβ 的缺失导致 RalA 和 RalB 的高活性,导致体外细胞迁移和侵袭增强,体内肿瘤生长和转移增强。